<DOC>
	<DOCNO>NCT00390585</DOCNO>
	<brief_summary>The purpose study demonstrate Iodixanol 320 associate low incidence contrast-induced nephropathy ( CIN ) compare hyperosmolar contrast medium Iomeprol 350 patient impaired renal function undergo percutaneous coronary intervention ( PCI ) .</brief_summary>
	<brief_title>Iodixanol vs. Iomeprol Prevent Contrast-Induced Nephropathy After Coronary Intervention ( CONTRAST )</brief_title>
	<detailed_description>Iodixanol , iso-osmolar , dimeric , non-ionic contrast agent show reduce risk develop CIN patient elevate serum creatinine concentration compare low-osmolar contrast agent . However , information available potential protective effect Iodixanol patient impair renal function CIN use PCI . Due high volume contrast exposition , patient impair renal function increase risk development CIN compare patient normal excretory renal function . The purpose investigation determine change renal function patient impaired renal function receive Iodixanol 320 Iomeprol 350 percutaneous coronary intervention .</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Arteriosclerosis</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<criteria>chronic renal failure Informed , write consent Cardiogenic shock Dialysis kidney transplantation Concurrent intake nephrotoxic medication Planned proceeded parenteral ( i.v . i.a . ) administration iodinecontaining contrast medium least 7 day before/after catheterization . Contraindications use Iodixanol ( e.g . allergy ) Women know pregnant , childbearing potential test positive pregnancy , give birth within last 90 day , breastfeed Patient 's inability fully cooperate study protocol . Previous enrollment trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>Renal Insufficiency</keyword>
	<keyword>Angioplasty , Transluminal , Percutaneous Coronary</keyword>
	<keyword>Contrast medium</keyword>
</DOC>